Wilson Wong | Profiles RNS

Wilson Wong, PhD

Associate Professor

Boston University College of Engineering

Biomedical Engineering

PhD, University of California, Los Angeles
BS, University of California, Berkeley

Websites

	LinkedIn
	Google Scholar
	Wong Lab
	College of Engineering Faculty
	AIChE Profile

ORCID : 0000-0001-8394-889X

Wilson Wong is an Assistant Professor for Biomedical Engineering at Boston University. He obtained his PhD in chemical engineering from the University of California, Los Angeles and his Bachelor's in chemical engineering from the University of California, Berkeley. His research interests are in applying metabolic engineering and immune cell engineering to rapidly and predictably engineer desired properties in human immune cells to treat diseases.

The Wong lab is a DESIGN driven lab where they apply synthetic biology to engineer desired properties in mammalian cells, with application in understanding cellular design principle and to treat diseases. One area that they are interested in is engineering genetic circuits to improve the efficacy and safety of adoptive T cell therapy. Here they are interested in using synthetic biology to design and construct novel signaling, transcription, and metabolic networks in cells for application in medicine and understanding design principles in living organisms. Specifically, they are interested in engineering human immune cells for adoptive cancer immunotherapy. Adoptive immunotherapy is a promising therapy for treatment of various cancers (1). Their goal at the Wong Lab is to engineer immune cells to enhance their disease fighting capability while minimizing adverse side effect. Also, by building novel networks inside immune cells, they can explore design principles by mapping network architecture to phenotype.

BU Research
NIH RePORTER Research

Precise tumor targeting with logic CAR circuits
09/17/2021 - 08/31/2026 (Multi-PI)
PI: Wilson Wong, PhD
NIH/National Cancer Institute
5U01CA265713-02

Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands
05/15/2022 - 04/30/2026 (PI)
NIH/National Diabetes & Digestive & Kidney Diseases
5R01DK132576-02

Targeting Fibroblast Discoidin Domain Receptor 2 for Immunotherapy to Pulmonary Fibrosis
12/01/2021 - 11/30/2025 (Subcontract PI)
Regents of the University of Michigan NIH NHLBI
5R01HL156998-02

Multiplexed Optogenetic Control of Mammalian Genome and Transcriptome using Recombinases and Cas13
07/01/2023 - 06/30/2025 (Key Person / Mentor)
NIH/National Institute of General Medical Sciences
1F31GM149163-01A1

Multiplexed and Logical Control of The Mammalian Transcriptome Using Cas13
09/20/2021 - 06/30/2025 (PI)
NIH/National Institute of Biomedical Imaging & Bioengineering
5R01EB031904-03

Engineering Branching Networks Through Synthetic Turing Morphogen Circuits
12/10/2021 - 12/09/2024 (Multi-PI)
PI: Wilson Wong, PhD
Allen Institute d/b/a The Paul G. Allen Frontiers Group

Design and in vivo comparison of alternative strategies for artificial Zinc Finger (aZnF) based regulatable gene therapies
03/04/2022 - 09/03/2024 (Multi-PI)
PI: Wilson Wong, PhD
Novartis Institutes for BioMedical Research

Synthetic morphogenesis to recapitulate multicellular airway branching patterns
04/01/2023 - 03/31/2024 (Key Person / Mentor)
PI: Ian Kinstlinger, PhD
NIH/National Heart, Lung, and Blood Institute
1F32HL160194-01A1

Advanced recombinase-based gene expression technology in mammalian cells
06/01/2019 - 02/29/2024 (PI)
NIH/National Institute of General Medical Sciences
5R01GM129011-04

Synthetic toolkit for precision gene expression control and signal processing in mammalian cells
05/01/2020 - 01/31/2024 (Multi-PI)
PI: Wilson Wong, PhD
NIH/National Institute of Biomedical Imaging & Bioengineering
5R01EB029483-04

Showing 10 of 24 results. Show All Results

Title

Yr	Title	Project-Sub Proj
2023	Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands	5R01DK132576-02
2023	Multiplexed and Logical Control of the Mammalian Transcriptome Using Cas13	5R01EB031904-03
2023	Precise tumor targeting with logic CAR circuits	5U01CA265713-03
2022	Multiplexed and Logical Control of the Mammalian Transcriptome Using Cas13	5R01EB031904-02
2022	Advanced recombinase-based gene expression technology in mammalian cells	3R01GM129011-04S1
2022	Advanced recombinase-based gene expression technology in mammalian cells	5R01GM129011-04
2021	Multiplexed and Logical Control of the Mammalian Transcriptome Using Cas13	1R01EB031904-01
2021	Precise tumor targeting with logic CAR circuits	1U01CA265713-01
2021	Advanced recombinase-based gene expression technology in mammalian cells	5R01GM129011-03
2020	Advanced recombinase-based gene expression technology in mammalian cells	3R01GM129011-02S1

Showing 10 of 14 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Zhang J, Shin J, Tague N, Lin H, Zhang M, Ge X, Wong W, Dunlop MJ, Cheng JX. Visualization of a Limonene Synthesis Metabolon Inside Living Bacteria by Hyperspectral SRS Microscopy. Adv Sci (Weinh). 2022 Nov; 9(32):e2203887.View Related Profiles.

Dunlop, Mary
Wong, Wilson

PMID: 36169112; PMCID: PMC9661820; DOI: 10.1002/advs.202203887;

Wong NM, Frias E, Sigoillot FD, Letendre JH, Hild M, Wong WW. Engineering digitizer circuits for chemical and genetic screens in human cells. Nat Commun. 2021 10 22; 12(1):6150. PMID: 34686672; PMCID: PMC8536748; DOI: 10.1038/s41467-021-26359-9;

Kiwimagi KA, Letendre JH, Weinberg BH, Wang J, Chen M, Watanabe L, Myers CJ, Beal J, Wong WW, Weiss R. Quantitative characterization of recombinase-based digitizer circuits enables predictable amplification of biological signals. Commun Biol. 2021 07 15; 4(1):875. PMID: 34267310; PMCID: PMC8282836; DOI: 10.1038/s42003-021-02325-5;

Lin H, Lee HJ, Tague N, Lugagne JB, Zong C, Deng F, Shin J, Tian L, Wong W, Dunlop MJ, Cheng JX. Microsecond fingerprint stimulated Raman spectroscopic imaging by ultrafast tuning and spatial-spectral learning. Nat Commun. 2021 05 24; 12(1):3052.View Related Profiles.

Cheng, Ji-Xin
Dunlop, Mary
Wong, Wilson

PMID: 34031374; PMCID: PMC8144602; DOI: 10.1038/s41467-021-23202-z;

Kim T, Weinberg B, Wong W, Lu TK. Scalable recombinase-based gene expression cascades. Nat Commun. 2021 05 11; 12(1):2711. PMID: 33976199; PMCID: PMC8113245; DOI: 10.1038/s41467-021-22978-4;

Tan X, Letendre JH, Collins JJ, Wong WW. Synthetic biology in the clinic: engineering vaccines, diagnostics, and therapeutics. Cell. 2021 02 18; 184(4):881-898. PMID: 33571426; PMCID: PMC7897318; DOI: 10.1016/j.cell.2021.01.017;

Cho JH, Okuma A, Sofjan K, Lee S, Collins JJ, Wong WW. Engineering advanced logic and distributed computing in human CAR immune cells. Nat Commun. 2021 02 04; 12(1):792. PMID: 33542232; PMCID: PMC7862674; DOI: 10.1038/s41467-021-21078-7;

Bowyer JE, Ding C, Weinberg BH, Wong WW, Bates DG. A mechanistic model of the BLADE platform predicts performance characteristics of 256 different synthetic DNA recombination circuits. PLoS Comput Biol. 2020 12; 16(12):e1007849. PMID: 33338034; PMCID: PMC7781486; DOI: 10.1371/journal.pcbi.1007849;

Lee S, Wong WW. The Most Logical Approach to Improve CAR T Cell Therapy. Cell Syst. 2020 11 18; 11(5):421-423. PMID: 33212015; DOI: 10.1016/j.cels.2020.10.008;

Olson A, Basukala B, Lee S, Gagne M, Wong WW, Henderson AJ. Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9. Viruses. 2020 10 12; 12(10).View Related Profiles.

Olson, Alex
Henderson, Andrew
Gagne, Matthew
Wong, Wilson

PMID: 33053801; PMCID: PMC7600714; DOI: 10.3390/v12101154;

Showing 10 of 30 results. Show More

Sheets MB, Wong WW, Dunlop MJ. Correction to Light-Inducible Recombinases for Bacterial Optogenetics. ACS Synth Biol. 2020 Oct 16; 9(10):2857-2859.View Related Profiles.

Dunlop, Mary
Wong, Wilson

PMID: 33001633; DOI: 10.1021/acssynbio.0c00477;

Chen YY, Lim W, Levings M, Blazar B, Krenciute G, Wong W, Lehner M. What is the Optimal Design-Build-Test Cycle for Clinically Relevant Synthetic CAR T Cell Therapies? Cell Syst. 2020 09 23; 11(3):212-214. PMID: 32970992; PMCID: PMC7861890; DOI: 10.1016/j.cels.2020.08.017;

Cho JH, Okuma A, Al-Rubaye D, Intisar E, Junghans RP, Wong WW. Author Correction: Engineering Axl specific CAR and SynNotch receptor for cancer therapy. Sci Rep. 2020 Feb 14; 10(1):3000. PMID: 32060414; PMCID: PMC7021703; DOI: 10.1038/s41598-020-59902-7;

Sheets MB, Wong WW, Dunlop MJ. Light-Inducible Recombinases for Bacterial Optogenetics. ACS Synth Biol. 2020 02 21; 9(2):227-235.View Related Profiles.

Dunlop, Mary
Wong, Wilson

PMID: 31961670; PMCID: PMC7393974; DOI: 10.1021/acssynbio.9b00395;

Weinberg BH, Cho JH, Agarwal Y, Pham NTH, Caraballo LD, Walkosz M, Ortega C, Trexler M, Tague N, Law B, Benman WKJ, Letendre J, Beal J, Wong WW. High-performance chemical- and light-inducible recombinases in mammalian cells and mice. Nat Commun. 2019 10 24; 10(1):4845.View Related Profiles.

Walkosz, Maciej
Wong, Wilson

PMID: 31649244; PMCID: PMC6813296; DOI: 10.1038/s41467-019-12800-7;

Olson A, Basukala B, Wong WW, Henderson AJ. Targeting HIV-1 proviral transcription. Curr Opin Virol. 2019 10; 38:89-96.View Related Profiles.

Olson, Alex
Henderson, Andrew
Wong, Wilson

PMID: 31473372; PMCID: PMC6854310; DOI: 10.1016/j.coviro.2019.07.011;

Chakravarti D, Caraballo LD, Weinberg BH, Wong WW. Inducible Gene Switches with Memory in Human T Cells for Cellular Immunotherapy. ACS Synth Biol. 2019 08 16; 8(8):1744-1754. PMID: 31268301; PMCID: PMC6703182; DOI: 10.1021/acssynbio.8b00512;

Gagne M, Michaels D, Schiralli Lester GM, Gummuluru S, Wong WW, Henderson AJ. Strength of T cell signaling regulates HIV-1 replication and establishment of latency. PLoS Pathog. 2019 05; 15(5):e1007802.View Related Profiles.

Henderson, Andrew
Schiralli Lester, Gillian
Gagne, Matthew
Gummuluru, Suryaram
Wong, Wilson

PMID: 31116788; PMCID: PMC6548398; DOI: 10.1371/journal.ppat.1007802;

Cho JH, Collins JJ, Wong WW. Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses. Cell. 2018 05 31; 173(6):1426-1438.e11. PMID: 29706540; PMCID: PMC5984158; DOI: 10.1016/j.cell.2018.03.038;

Wong NML, Wong WW. Engineering a Dual Small Molecule Gated ZAP70 Switch in T Cells. ACS Synth Biol. 2018 04 20; 7(4):969-977. PMID: 29589904; PMCID: PMC5985775; DOI: 10.1021/acssynbio.7b00394;

Cho JH, Okuma A, Al-Rubaye D, Intisar E, Junghans RP, Wong WW. Engineering Axl specific CAR and SynNotch receptor for cancer therapy. Sci Rep. 2018 03 01; 8(1):3846. PMID: 29497107; PMCID: PMC5832765; DOI: 10.1038/s41598-018-22252-6;

Brenner MJ, Cho JH, Wong NML, Wong WW. Synthetic Biology: Immunotherapy by Design. Annu Rev Biomed Eng. 2018 06 04; 20:95-118. PMID: 29345976; DOI: 10.1146/annurev-bioeng-062117-121147;

Weinberg BH, Pham NTH, Caraballo LD, Lozanoski T, Engel A, Bhatia S, Wong WW. Large-scale design of robust genetic circuits with multiple inputs and outputs for mammalian cells. Nat Biotechnol. 2017 May; 35(5):453-462.View Related Profiles.

Bhatia, Swapnil
Wong, Wilson

PMID: 28346402

Brenner M, Cho JH, Wong WW. Synthetic biology: Sensing with modular receptors. Nat Chem Biol. 2017 01 19; 13(2):131-132. PMID: 28103225; DOI: 10.1038/nchembio.2290;

Aquino P, Honda B, Jaini S, Lyubetskaya A, Hosur K, Chiu JG, Ekladious I, Hu D, Jin L, Sayeg MK, Stettner AI, Wang J, Wong BG, Wong WS, Alexander SL, Ba C, Bensussen SI, Bernstein DB, Braff D, Cha S, Cheng DI, Cho JH, Chou K, Chuang J, Gastler DE, Grasso DJ, Greifenberger JS, Guo C, Hawes AK, Israni DV, Jain SR, Kim J, Lei J, Li H, Li D, Li Q, Mancuso CP, Mao N, Masud SF, Meisel CL, Mi J, Nykyforchyn CS, Park M, Peterson HM, Ramirez AK, Reynolds DS, Rim NG, Saffie JC, Su H, Su WR, Su Y, Sun M, Thommes MM, Tu T, Varongchayakul N, Wagner TE, Weinberg BH, Yang R, Yaroslavsky A, Yoon C, Zhao Y, Zollinger AJ, Stringer AM, Foster JW, Wade J, Raman S, Broude N, Wong WW, Galagan JE. Coordinated regulation of acid resistance in Escherichia coli. BMC Syst Biol. 2017 Jan 06; 11(1):1.View Related Profiles.

Galagan, James
Wong, Wilson

PMID: 28061857; PMCID: PMC5217608; DOI: 10.1186/s12918-016-0376-y;

Bowyer J, Zhao J, Subsoontorn P, Wong W, Rosser S, Bates D. Mechanistic Modeling of a Rewritable Recombinase Addressable Data Module. IEEE Trans Biomed Circuits Syst. 2016 12; 10(6):1161-1170. PMID: 27244749

Chakravarti D, Cho JH, Weinberg BH, Wong NM, Wong WW. Synthetic biology approaches in cancer immunotherapy, genetic network engineering, and genome editing. Integr Biol (Camb). 2016 Apr 18; 8(4):504-17. PMID: 27068224; DOI: 10.1039/c5ib00325c;

Chakravarti D, Wong WW. Synthetic biology in cell-based cancer immunotherapy. Trends Biotechnol. 2015 Aug; 33(8):449-61. PMID: 26088008; PMCID: PMC4509852; DOI: 10.1016/j.tibtech.2015.05.001;

Sayeg MK, Weinberg BH, Cha SS, Goodloe M, Wong WW, Han X. Rationally Designed MicroRNA-Based Genetic Classifiers Target Specific Neurons in the Brain. ACS Synth Biol. 2015 Jul 17; 4(7):788-795.View Related Profiles.

Wong, Wilson
Han, Xue

PMID: 25848814; PMCID: PMC4547530; DOI: 10.1021/acssynbio.5b00040;

Wei P, Wong WW, Park JS, Corcoran EE, Peisajovich SG, Onuffer JJ, Weiss A, Lim WA. Bacterial virulence proteins as tools to rewire kinase pathways in yeast and immune cells. Nature. 2012 Aug 16; 488(7411):384-8. PMID: 22820255

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 30 publications over 9 distinct years, with a maximum of 7 publications in 2020